Location:
dCas9-GFP-VP64

dCas9-GFP-VP64 Transcriptional Activator


Product Introduction

dCas9-GFP-VP64 is a multifunctional chimeric protein that fuses nuclease-dead Cas9 (dCas9), Green Fluorescent Protein (GFP), and the VP64 transcriptional activation domain into a single entity, enabling the integration of gene targeting, real-time visualization, and transcriptional regulation. The dCas9 moiety of this protein carries the D10A and N863A double mutations, completely abolishing DNA cleavage activity while fully retaining the ability to precisely bind specific DNA sequences guided by sgRNA. GFP serves as a fluorescent reporter tag; its stable folding and bright fluorescence provide a convenient optical tool for real-time tracking of the protein's subcellular localization, dynamic distribution, and target binding process. The VP64 domain consists of four tandem copies of the herpes simplex virus VP16 transcriptional activation domain, possessing the potent ability to recruit transcriptional machinery.

When a specific sgRNA guides dCas9-GFP-VP64 to bind to the promoter region of a target gene, the VP64 domain recruits factors such as the pre-initiation complex and histone acetyltransferases, promoting the assembly of RNA polymerase II and transcription initiation, thereby achieving transcriptional upregulation of the target gene.

Product Specifications

Parameter

Specification

Source

Recombinant expression in E. coli

Molecular Weight

201 kDa

Concentration

20 μM

PAM Sequence

5'-NGG-3'

Mutation Sites

D10A + N863A

Activation Domain

VP64

Purity

≥95% (SDS-PAGE)

Endotoxin

<1 EU/μg

Storage Buffer

50 mM Tris-HCl, 300 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 50% Glycerol

10× Reaction Buffer

50 mM Tris-HCl, 100 mM NaCl, 10 mM MgCl₂, 100 μg/ml BSA, pH 7.9

Storage Conditions

Long-term storage at -80°C; short-term storage at -20°C

Product Specifications

Specifications

Catalog Number

Concentration

Volume

100 pmol

GR101901

20 μM

5 μL

500 pmol

GR101902

20 μM

25 μL

2500 pmol

GR101903

20 μM

125 μL

Application Scenarios

Gene Transcriptional Activation: Upregulating endogenous gene expression.

Gain-of-Function Screening: Genome-wide CRISPRa screens.

Cellular Reprogramming: Activating pluripotency-related genes to promote cell fate conversion.

Epigenetics Research: Studying the impact of transcriptional activation on chromatin states.

Gene Function Studies: Serving as an alternative to cDNA overexpression for functional studies.

Drug Target Validation: Validating therapeutic strategies by activating potential target genes.

References

Gilbert LA, et al. (2013). CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell. 154(2):442-451.

Perez-Pinera P, et al. (2013). RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods. 10(10):973-976.

Chavez A, et al. (2015). Highly efficient Cas9-mediated transcriptional programming. Nat Methods. 12(4):326-328.

Ramu G, et al. (2018). Paired D10A Cas9 nickases are sometimes more efficient than individual nucleases for gene disruption. Nucleic Acids Res. 46(12):e71.